Addyi 100 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y0F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,610
Award facts
- Contract value 100% obligated
- $11,609.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of ADDYI (flibansererin) 100 mg tablets in quantities of 30 units, with a ceiling value of $11,609.59. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This primary vehicle enables the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The delivery order is scheduled for ultimate completion on January 27, 2026, representing a routine fulfillment of pharmaceutical needs under the broader IDC framework that allows flexible procurement of essential medical commodities for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6Y0F?
SPE2DR26F6Y0F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F6Y0F worth?
The government has obligated $11,610 on SPE2DR26F6Y0F.
Is contract SPE2DR26F6Y0F an order under another contract?
Yes. SPE2DR26F6Y0F is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y0F competed?
The extent of competition for SPE2DR26F6Y0F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award